awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33430113-A5FEB405-9A2C-4455-9CB6-7B41880F98C6
Q33430113-A5FEB405-9A2C-4455-9CB6-7B41880F98C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33430113-A5FEB405-9A2C-4455-9CB6-7B41880F98C6
Alleviating anemia and thrombocytopenia in myelofibrosis patients.
P2860
Q33430113-A5FEB405-9A2C-4455-9CB6-7B41880F98C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33430113-A5FEB405-9A2C-4455-9CB6-7B41880F98C6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c414872daaa4130670ffc465fb84b3e89893e0f7
P2860
U.S. Food and Drug Administration approval: ruxolitinib for the treatment of patients with intermediate and high-risk myelofibrosis.